Free tool
Stocks listed on B3 São Paulo
We cover 42 companies listed on B3 São Paulo. The median market value in the group is $11.17B. Across the group, the median move over the past trading day is 0.00%. 42% of the 36 with a 200-day average trade above it. Price change over the past year runs from −26.1% to +67.0% across the middle 80 percent of the group, with a median of +8.7%.
Other lists in this group
Table
42 of 2,037 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| ABTT34.SA | Abbott Laboratories | $199.23B | Large cap | −16.35% |
| DHER34.SA | Danaher Corporation | $151.72B | Large cap | +0.89% |
| I1SR34.SA | Intuitive Surgical, Inc. | $132.60B | Large cap | −25.36% |
| S1YK34.SA | Stryker Corporation | $126.60B | Large cap | −19.51% |
| G1SK34.SA | GSK plc | $104.64B | Large cap | +27.31% |
| E1LV34.SA | Elevance Health, Inc. | $86.53B | Large cap | +21.66% |
| REGN34.SA | Regeneron Pharmaceuticals, Inc. | $85.16B | Large cap | +33.80% |
| M1RN34.SA | Moderna, Inc. | $63.51B | Large cap | +462.13% |
| C1AH34.SA | Cardinal Health, Inc. | $55.77B | Large cap | +52.41% |
| E1WL34.SA | Edwards Lifesciences Corporation | $47.29B | Large cap | −4.72% |
| H1UM34.SA | Humana Inc. | $46.72B | Large cap | +24.36% |
| I1DX34.SA | IDEXX Laboratories, Inc. | $44.35B | Large cap | −17.31% |
| D1EX34.SA | DexCom, Inc. | $33.75B | Large cap | +9.64% |
| C1NC34.SA | Centene Corporation | $32.65B | Large cap | +116.61% |
| Z1TS34.SA | Zoetis Inc. | $32.03B | Large cap | −52.31% |
| A1LN34.SA | Alnylam Pharmaceuticals, Inc. | $31.78B | Large cap | −49.35% |
| RDOR3.SA | Rede D'Or São Luiz S.A. | $14.92B | Large cap | +1.37% |
| B1AX34.SA | Baxter International Inc. | $13.60B | Large cap | +3.61% |
| R1VT34.SA | Revvity, Inc. | $12.50B | Large cap | +22.81% |
| DVAI34.SA | DaVita Inc. | $11.70B | Large cap | +18.80% |
| A1LG34.SA | Align Technology, Inc. | $11.51B | Large cap | +7.83% |
| I1QV34.SA | IQVIA Holdings Inc. | $10.82B | Large cap | −67.19% |
| S1RP34.SA | Sarepta Therapeutics, Inc. | $1.98B | Small cap | −12.20% |
| FLRY3.SA | Fleury S.A. | $1.97B | Small cap | +37.82% |
| A2RR34.SA | Arrowhead Pharmaceuticals, Inc. | $1.58B | Small cap | +298.89% |
| T2DH34.SA | Teladoc Health, Inc. | $1.13B | Small cap | −24.67% |
| J2AZ34.SA | Jazz Pharmaceuticals plc | $1.08B | Small cap | +35.66% |
| B2RK34.SA | Bruker Corporation | $906.52M | Small cap | +63.27% |
| D2OC34.SA | Doximity, Inc. | $733.94M | Small cap | −65.76% |
| C2RS34.SA | CRISPR Therapeutics AG | $704.10M | Small cap | +0.85% |
| DASA3.SA | Diagnósticos da América S.A. | $633.57M | Small cap | +93.33% |
| PGMN3.SA | Empreendimentos Pague Menos S.A. | $481.69M | Small cap | −1.57% |
| BLAU3.SA | Blau Farmacêutica S.A. | $406.91M | Small cap | −2.28% |
| PNVL3.SA | Dimed S.A. Distribuidora de Medicamentos | $350.76M | Small cap | +20.56% |
| P2OD34.SA | Insulet Corporation | $332.45M | Small cap | −26.20% |
| MATD3.SA | Hospital Mater Dei S.A. | $321.33M | Small cap | +11.78% |
| OFSA3.SA | Ouro Fino Saúde Animal Participações S.A. | $256.27M | Small cap | +18.69% |
| R2AR34.SA | Ultragenyx Pharmaceutical Inc. | $255.25M | Small cap | +11.74% |
| N2VC34.SA | NovoCure Limited | $202.19M | Small cap | +67.42% |
| PFRM3.SA | Profarma Distribuidora de Produtos Farmacêuticos S.A. | $177.65M | Small cap | −1.92% |
| BIOM3.SA | Biomm S.A. | $171.18M | Small cap | +0.63% |
| T2ND34.SA | Tandem Diabetes Care, Inc. | $110.42M | Small cap | +41.78% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.